arabinofuranosylcytosine triphosphate has been researched along with als-8176 in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Beigelman, L; Blatt, LM; Chanda, SM; Deval, J; Dyatkina, N; Fung, A; Hong, J; Jin, Z; Liu, J; Prhavc, M; Serebryany, V; Smith, DB; Stevens, SK; Symons, JA; Tam, Y; Taylor, J; Wang, G; Zhang, Q | 1 |
1 other study(ies) available for arabinofuranosylcytosine triphosphate and als-8176
| Article | Year |
|---|---|
Discovery of 4'-chloromethyl-2'-deoxy-3',5'-di-O-isobutyryl-2'-fluorocytidine (ALS-8176), a first-in-class RSV polymerase inhibitor for treatment of human respiratory syncytial virus infection.
Topics: Animals; Antiviral Agents; Cricetinae; Deoxycytidine; DNA-Directed DNA Polymerase; DNA-Directed RNA Polymerases; Dose-Response Relationship, Drug; Drug Discovery; Enzyme Inhibitors; Haplorhini; Humans; Male; Molecular Conformation; Poly(ADP-ribose) Polymerase Inhibitors; Poly(ADP-ribose) Polymerases; Prodrugs; Rats; Rats, Sprague-Dawley; Respiratory Syncytial Virus Infections; Respiratory Syncytial Viruses; Structure-Activity Relationship; Virus Replication | 2015 |